Literature DB >> 15849773

RBM15-MKL1 (OTT-MAL) fusion transcript in an adult acute myeloid leukemia patient.

Hui-Hua Hsiao1, Ming-Yu Yang, Yi-Chang Liu, Hui-Pin Hsiao, Shih-Bin Tseng, Mei-Chyn Chao, Ta-Chih Liu, Sheng-Fung Lin.   

Abstract

The t(1;22)(p13;q13) is a nonrandom chromosomal abnormality in acute leukemia with the fusion oncogene, RBM15-MKL1 (OTT-MAL), identified recently. However, this abnormality has been described only in infants and young children with acute megakaryoblastic leukemia (AMKL). We report a 59-year-old male patient with the diagnosis of acute myeloid leukemia, subtype M1, who harbors an abnormal chromosome +der(1)t(1;22)(p13;q13). The RBM15-MKL1 (OTT-MAL) fusion transcript was also confirmed by the reverse transcriptase-polymerase chain reaction. This unusual abnormality is rare in adult cases of leukemia, and in children it is restricted to AMKL. This report is accompanied by a review of the literature on the t(1;22)(p13;q13). 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849773     DOI: 10.1002/ajh.20298

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma.

Authors:  Dali Huang; Janos Sumegi; Paola Dal Cin; John D Reith; Taketoshi Yasuda; Marilu Nelson; David Muirhead; Julia A Bridge
Journal:  Genes Chromosomes Cancer       Date:  2010-09       Impact factor: 5.006

2.  Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation.

Authors:  Xianyong Ma; Matthew J Renda; Lin Wang; Ee-Chun Cheng; Chao Niu; Stephan W Morris; Andrew S Chi; Diane S Krause
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

Review 3.  RNA-Binding Proteins in Acute Leukemias.

Authors:  Konstantin Schuschel; Matthias Helwig; Stefan Hüttelmaier; Dirk Heckl; Jan-Henning Klusmann; Jessica I Hoell
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

4.  RBM15 condensates modulate m6A modification of STYK1 to promote tumorigenesis.

Authors:  Amin Jiang; Siwei Zhang; Xinyu Wang; Dong Li
Journal:  Comput Struct Biotechnol J       Date:  2022-09-05       Impact factor: 6.155

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.